1-(4-Nitrophenyl)piperidin-2-one | CAS:38560-30-4

We serve 1-(4-Nitrophenyl)piperidin-2-one CAS:38560-30-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-(4-Nitrophenyl)piperidin-2-one

Chemical Name:1-(4-Nitrophenyl)piperidin-2-one
CAS.NO:38560-30-4
Synonyms:1-(4-Nitrophenyl)piperidin-2-one
1-(4-Nitrophenyl)-2-piperidone
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 480.9±28.0 °C at 760 mmHg
Molecular Formula C11H12N2O3
Molecular Weight 220.225
Flash Point 244.7±24.0 °C
 
Specification:
Appearance:Yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Apixaban(CAS:503612-47-3).



Contact us for information like 1-(4-Nitrophenyl)piperidin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-Nitrophenyl)-2-piperidone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-Nitrophenyl)-2-piperidone Use and application,1-(4-Nitrophenyl)piperidin-2-one technical grade,usp/ep/jp grade.


Related News: Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.4-octylbenzoic acid manufacturer The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.4-Fluoroanisole supplier Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.2,5-dichloro-thiophene-3,4-dicarboxylic acid vendor Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.